We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JYNT:NASDAQThe Joint Corp. Analysis

Data as of 2026-08-26 - not real-time

$8.45

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind The Joint Corp. is bearish at $8.45, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 5.6%. Relative strength is 48.5 — neutral — and the MACD signal is bullish. The recent range runs from support at $7.96 up to resistance at $8.91.
Multiples put this in overvalued territory: 60.4 times earnings against the sector's 31.2. Sell-side targets cluster 18.3% above the current quote. Revenue is growing at 14.4% on a 6.5% profit margin.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 28.4%, a beta of 0.82 and a maximum drawdown of 29.5%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 2/10 conviction on the long call.

Top Market Events

The Joint Corp JYNT reports a 14% revenue surge and a $1.- Consolidated Net Income Increases $560,000 to $653,000; Adjusted EBITDA From Continuing Operations Increases by $1.Seeking Alpha18dThe Joint Corp. JYNT Q2 2026 Earnings Call TranscriptThank you for standing by. My name is Rebecca, and...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 8.81
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 60.4 versus sector average of 31.2
  • Trading below the 200-day average of 8.81

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 60.4 versus sector average of 31.2
  • Analyst targets imply +18.3% versus the current price
  • Revenue growth of +14.4%

Key Metrics & Analysis

Financial Health

Revenue Growth14.40%
Profit Margin6.49%
P/E Ratio60.4
ROE10.62%
ROA2.33%
Debt/Equity12.83
P/B Ratio7.3
Op. Cash Flow$5.4M
Free Cash Flow$4.0M
Industry P/E31.2

Technical Analysis

TrendBearish
RSI48.5
Support$7.96
Resistance$8.91
MA 20$8.39
MA 50$8.71
MA 200$8.81
MACDBullish
VolumeDecreasing
Fear & Greed Index93.84

Valuation

Fair Value$7.96
Target Price$10.00
Upside/Downside18.34%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.82
Volatility28.44%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.